Prot: 254PD101- A Phase 1 Single- and Multiple-Ascending-Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB094 Administered Intrathecally to Adults With Parkinson’s Disease

Project: Research project

Project Details

StatusActive
Effective start/end date11/27/1911/27/22

Funding

  • Quintiles, Inc. (Prot: 254PD101)
  • Biogen MA Inc. (Prot: 254PD101)